On February 13, 2026, Affinity Asset Advisors disclosed a purchase of 61,500 shares of Apogee Therapeutics (NASDAQ:APGE), an estimated $3.87 million trade based on quarterly average pricing. According to an SEC filing dated February 13, 2026, Affinity Asset Advisors, LLC Read More
